Euclidean Capital LLC FHTX Holdings History
Euclidean Capital LLC's Foghorn Therapeutics Inc Holding Summary
As of 2025-03-31, Euclidean Capital LLC held 1.57 Mil shares of Foghorn Therapeutics Inc(FHTX), totaling $5.74 Mil. This investment constitutes 2.16% of their stock portfolio, and Euclidean Capital LLC now holds 2.82% of the outstanding Foghorn Therapeutics Inc(FHTX) stock.
The initial trade took place in 2020Q4. And since then Euclidean Capital LLC has made 2 purchases of FHTX, at an average price of $12.23, for a total of 3.15 Mil shares. In addition, there have been 1 sales at an average price of $4.31 for 1.57 Mil shares. Based on historical transaction data and FHTX's current price of $4.89, Euclidean Capital LLC's estimated gain on his FHTX holdings is $-24.00 Mil, reflecting a -62.37% gain to date.
Euclidean Capital LLC FHTX ($4.89) Holding Chart
Euclidean Capital LLC FHTX ($4.89) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
